FDA NDC Directory · JSON-LD · Markdown

Rivastigmine Tartrate

NDC 0904-7107 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerMajor Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA204572
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIVASTIGMINE TARTRATE (1.5 mg/1)
Marketing started20160325
Package count1

External sources

Source: openFDA. Public-domain (CC0).